Quest Diagnostics Q2 2024 Adj EPS $2.35 Beats $2.34 Estimate, Sales $2.397B Beat $2.390B Estimate
Portfolio Pulse from Benzinga Newsdesk
Quest Diagnostics reported Q2 2024 adjusted EPS of $2.35, beating the estimate of $2.34. Sales were $2.397 billion, also surpassing the estimate of $2.390 billion.
July 23, 2024 | 10:47 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Quest Diagnostics reported better-than-expected Q2 2024 results with an adjusted EPS of $2.35 and sales of $2.397 billion, both surpassing estimates.
The company's better-than-expected earnings and sales figures are likely to boost investor confidence and positively impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100